Alkem Laboratories has completed the transfer of its trade generics business to Alkem Wellness Limited, a wholly-owned subsidiary. The transfer, structured as a business transfer agreement, is effective from October 1, 2025. This move aims to streamline operations and focus on synergistic growth opportunities within the wellness segment. The announcement was made on September 26, 2025.
Business Transfer Effective
Alkem Laboratories announced that the transfer of its trade generics business to Alkem Wellness Limited has been completed. Alkem Wellness is a wholly-owned subsidiary of Alkem Laboratories.
Key Details of the Transfer
The business transfer was structured through a Business Transfer Agreement and became effective on October 1, 2025. The initial announcement regarding the intent to transfer was made on December 10, 2024. This move enables Alkem Laboratories to optimize its business portfolio.
Source: BSE
